ChestEze

A British over-the-counter pharmaceutical product manufactured by Novartis1 for "relief of bronchial cough, wheezing, breathlessness and other symptoms of asthmatic bronchitis and to clear the chest of mucus following upper respiratory tract infection." It contains 30 mg caffeine, 18.31 mg ephedrine hydrochloride and 100 mg anhydrous theophylline.

On 15 August 2015 ChestEze became discontinued and is no longer available to purchase

by SPrice1980 April 27, 2023